High Throughput Sequencing (HTS. Technology ▪ The use of established HTS technologies for diagnostics for the purpose of therapeutics or to determine the pathogen status of plants intended as nuclear stock is allowed as a supported Network cost. This includes conducting methods development studies that compare the efficacy of HTS against other diagnostic technologies but only to the extent that such studies are conducted for known pathogens of concern to industry. Network resources may not be used for comparison studies intending to pursue novel or unknown pathogens.
